Lucy Wangari Muchiri

The Clinical Value of Screening for Cervical Cancer using the High Risk Human Papilloma Virus (HR-HPV) and Liquid Based Cytology (LBC) Co-Testing Approach Compared to Screening with Individual Tests in Harare, Zimbabwe

Raymond Chibvongodze, Tafadzwa Dupwa, Elson Mberi, Chantal Nyirakanani & Lucy Wangari Muchiri · Asian Research Journal of Gynaecology and Obstetrics · 2021

Background: Cervical cancer is the most common malignancy in Zimbabwe. This attributed  to poorly executed Pap smear based screening programs. Pap smears have poor sensitivity and high specificity while HR-HPV DNA testing has high sensitivity and poor specificity. With reference...

Open access Research Article

High Risk Human Papillomavirus (Hr-HPV) Prevalence and Genotypes Detected in Women ≥ 30 Years Old who have Never been Screened for Cervical Cancer in Harare, Zimbabwe

Raymond Chibvongodze, Tafadzwa Dupwa, Elson Mberi, Chantal Nyirakanani & Lucy Wangari Muchiri · Asian Research Journal of Gynaecology and Obstetrics · 2021

Background: Almost 50% of all cervical cancer cases are diagnosed in patients who have never been screened for cervical cancer before. There is an established cause - effect relationship between Hr-HPV infection and cervical cancer. Therefore, knowing the prevalence and high risk...

Open access Research Article